Valuation: Gedeon Richter

Market Cap 2,377B 7.53B 6.52B 6.11B 5.57B 10.47B 718B 10.64B 71.85B 28.08B 359B 28.25B 27.64B 1,198B P/E 2026 *
9.13x
P/E 2027 * 8.28x
Enterprise Value 2,059B 6.52B 5.65B 5.29B 4.83B 9.07B 622B 9.21B 62.23B 24.33B 311B 24.47B 23.94B 1,038B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.91x
Free-Float
72.87%
Yield 2026 *
4.41%
Yield 2027 * 5.13%
1 week+6.05%
Current month+9.12%
1 month+4.18%
3 months-0.23%
6 months+14.26%
Current year+36.34%
1 week 33
Extreme 33
36.06
1 month 31.72
Extreme 31.72
36.06
Manager TitleAgeSince
Chief Executive Officer 47 2017-10-31
Director of Finance/CFO - 2025-04-30
Chief Operating Officer - 2018-12-31
Director TitleAgeSince
Chairman 78 2016-12-31
Chairman 90 2024-02-29
Director/Board Member 65 2012-04-25
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+6.05%+33.66% - 7.53B
+0.10%-1.02%+20.87%+71.68% 48.85B
-2.47%+1.96%+56.83%+119.26% 41.43B
+1.18%+6.64%+26.11%+85.11% 12.46B
0.00%+0.21%-2.78%+17.02% 12.39B
+0.96%-0.57%+30.73%+135.91% 9.08B
-0.08%+9.04%+25.29%+40.11% 7.53B
-0.12%+4.72%+41.49%-13.56% 7.14B
+0.62%+2.92%+11.75%+185.77% 6.73B
-0.87%+3.55%-25.69%+28.51% 5.88B
Average -0.08%+3.63%+21.83%+74.42% 16.83B
Weighted average by Cap. -0.50%+3.49%+29.00%+82.99%

Financials

2026 *2027 *
Net sales 975B 3.09B 2.67B 2.51B 2.28B 4.3B 294B 4.36B 29.46B 11.52B 147B 11.59B 11.33B 491B 1,026B 3.25B 2.81B 2.64B 2.41B 4.52B 310B 4.59B 31.01B 12.12B 155B 12.2B 11.93B 517B
Net income 265B 840M 728M 682M 622M 1.17B 80.11B 1.19B 8.02B 3.13B 40.11B 3.15B 3.09B 134B 288B 912M 790M 741M 675M 1.27B 87.01B 1.29B 8.71B 3.4B 43.57B 3.43B 3.35B 145B
Net Debt -318B -1.01B -872M -817M -746M -1.4B -96.04B -1.42B -9.61B -3.76B -48.09B -3.78B -3.7B -160B -421B -1.33B -1.16B -1.08B -988M -1.86B -127B -1.89B -12.74B -4.98B -63.72B -5.01B -4.9B -212B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
-
Date Price Change
26-08-12 35.84 +1.19%
26-08-11 €35.42 +0.68%
26-08-10 €35.18 +4.52%
26-08-07 €33.66 +1.39%
26-08-06 €33.20 -0.48%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
13,030.00HUF
Average target price
12,928.86HUF
Spread / Average Target
-0.78%

Quarterly revenue - Rate of surprise